Hangyi yang

Ms. Hangyi yang

Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2022 in Brain Sciences
Verified
Journal Article
Open access
PDF file
YHYueqi Huang
Yueqi Huang
Hangyi yangHangyi yang
Hangyi yang
CZCheng Zhu
Cheng Zhu
XJXiaoying Jiang
Xiaoying Jiang
WZWenjing Zhu
Wenjing Zhu
WTWenxin Tang
Wenxin Tang
Objective: To explore whether a systematic combined therapeutic modality (CTM) could quickly and effectively improve the severity of obsessive–compulsive disorder (OCD) and the insight of OCD patients. Methods: Included in this study were 100 patients with OCD according to the 5th Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), for a 2-week short-term treatment. They were assigned to a drug-alone group (n = 57), and a CTM group (n = 43) using drug treatment in combination with cognitive behavioral treatment (CBT) and repetitive transcranial magnetic stimulation (rTMS). The therapeutic outcome was assessed by the Yale–Brown Obsessive–Compulsive Scale (Y-BOCS), Brown Assessment of Beliefs Scale (BABS), 24-item Hamilton Depression Scale (HAMD-24) and Hamilton Anxiety Scale (HAMA) before and after treatment. All data were treated with SPSS25.0 Software. Results: After the 2-week treatment, the success rate in the CTM group was significantly higher than that in the drug-alone group. Y-BOCS overall and factor scores were decreased as compared with those before treatment in both groups. HAMD, HAMA and BABS overall scores were all decreased after treatment in the CTM group. In addition, compared with the drug-alone group, the Y-BOCS overall score and factor score, HAMD overall score and HAMA overall score were all decreased significantly in CTM group, while the Y-BOCS score reduction rate was increased significantly. Insight was improved in eight cases (57.14%) in the CTM group containing 14 cases with poor insight. Multinomial logistic regression analysis showed that CTM was beneficial for the insight improvement of OCD patients (OR = 91.04–139.68); this improvement was more pronounced in patients with low baseline BABS overall scores (OR = 0.07). Conclusion: CTM may be an effective short-term strategy to improve the severity of OCD and insight of OCD patients and, therefore, is worthy of clinical promotion and application.

1 January 2025 in Depression and Anxiety
Verified
Journal Article
Open access
LFLeqin Fang
Leqin Fang
WZWeixiong Zeng
Weixiong Zeng
SZShuqiong Zheng
Shuqiong Zheng
SDShixu Du
Shixu Du
Hangyi yangHangyi yang
Hangyi yang
BZBin Zhang
Bin Zhang
Clinically significant anxiety (CSA) is common in individuals with short‐term insomnia. This study aims to explore the relationship between CSA and the subjective and objective parameters of sleep in patients with short‐term insomnia and construct machine learning (ML) models to determine the utility of accelerometer features in identifying significant anxiety. A total of 205 short‐term insomnia participants from China were assigned to the group with CSA ( N = 33) or the group without CSA ( N = 172). Interaction analysis based on linear regression was used to estimate the possible interactive effect of accelerometer features between CSA and sleep problems. Four feature sets and eight algorithms were used to construct ML models, with Shapley Additive exPlanations (SHAP) values used to visualize feature importance and influence processes. CSA in patients with short‐term insomnia leads to more severe subjective sleep problems, and accelerometer‐measured features warrant further attention for the identification of interactive factors. A significant interaction effect was found between anxiety symptoms and longer duration of physical activity on insomnia severity ( P interaction < 0.05). Anxiety symptoms and interdaily stability had an interactive association with sleep hygiene behaviors ( P interaction < 0.01). ML can process and analyze complex accelerometer features to identify CSA in patients with short‐term insomnia. Compared with other feature sets and algorithms, the XGBoost model with accelerometer‐measured features on weekdays more effectively identified CSA with area under the curve (AUC) value of 0.777. SHAP analysis results indicated that circadian rhythm features had significant contributions. Decision plots based on SHAP were applied to visualize the personalized risk factors for each patient and provide clinicians with more easily understandable and practical explanation methods that enhance clinical decision‐making. Trial Registration: Chinese Clinical Trial Registry identifier: ChiCTR2200062910

1 January 2025 in Depression and Anxiety
Verified
Journal Article
Open access
XLXue Luo
Xue Luo
SZShuqiong Zheng
Shuqiong Zheng
YCYihong Cheng
Yihong Cheng
SLShuai Liu
Shuai Liu
SZShufei Zeng
Shufei Zeng
BZBin Zhang
Bin Zhang
Background: This study investigated the relationships between anxiety, depression symptoms, and C‐reactive protein (CRP) across insomnia severity levels using network analysis and examined the structural differences within these networks. Methods: Gaussian graphical model network analysis with Least Absolute Shrinkage and Selection Operator (LASSO) regularization was conducted on UK Biobank data ( N = 143,027). Depression and anxiety symptoms were assessed using the 9‐item Patient Health Questionnaire (PHQ‐9) and 7‐item Generalized Anxiety Disorder Scale (GAD‐7), respectively. CRP was quantified using immunoturbidimetric‐high‐sensitivity analysis. Participants were categorized by insomnia frequency (never/rarely, sometimes, and usually). The strength symptoms and expected influence identified core symptoms, while bridge expected influence (bridge EI) determined bridge symptoms. Network comparison tests (NCTs) were performed pairwise across the three groups to assess differences in global strength and edge weights. Results: Across all networks, “Depressed mood” demonstrated the highest strength centrality, while “Irritability” exhibited the highest bridge EI. “Depressed mood” had the highest expected influence centrality in the never/rarely insomnia group and “Uncontrollable worry” in other groups. NCTs revealed significant differences in global strength ( S = 0.178, p < 0.01) and edge weights ( M = 0.062, p < 0.01) between the never/rarely and usually insomnia groups, with stronger connections between depressive symptoms (energy/appetite) and CRP in the usually insomnia group ( p < 0.001). Conclusions: The central roles of depressed mood, uncontrollable worry, and irritability in the anxiety–depression–CRP network across all insomnia severity groups suggest that these symptoms represent potential targets for future intervention research. Notably, network structure differed across insomnia severity; the strengthened associations between depressive symptoms and CRP in the usually insomnia group suggest that insomnia severity may be an important factor to consider in understanding the relationships between affective and inflammatory processes.